This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herbst, R S
Right arrow Articles by Babiss, L E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbst, R S
Right arrow Articles by Babiss, L E

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 August; 10(8): 3896-3905

The mouse albumin enhancer contains a negative regulatory element that interacts with a novel DNA-binding protein.

R S Herbst, E M Boczko, J E Darnell Jr and L E Babiss

Rockefeller University, New York, New York 10021.

ABSTRACT

The far-upstream mouse albumin enhancer (-10.5 to -8.43 kilobases) has both positive and negative regulatory domains which contribute to the rate and tissue specificity of albumin gene transcription. (R. S. Herbst, N. Friedman, J. E. Darnell, Jr., and L. E. Babiss, Proc. Natl. Acad. Sci. USA 86:1553-1557). In this work, the negative regulatory region has been functionally localized to sequences -8.7 to -8.43 kilobases upstream of the albumin gene cap site. In the absence of the albumin-modulating region (in which there are binding sites for the transcription factor C/EBP), the negative region can suppress a neighboring positive-acting element, thereby interfering with albumin enhancer function. The negative region is also capable of negating the positive action of the heterologous transthyretin enhancer in an orientation-independent fashion. Within this negative-acting region we can detect two DNA-binding sites, both of which are recognized by a protein present in all cell types tested. This DNA-binding activity is not competed for by any of a series of known DNA-binding sites, and hence this new protein is a candidate for a role in suppressing the albumin gene in nonhepatic cells.


Mol Cell Biol. 1990 August; 10(8): 3896-3905




This article has been cited by other articles:

  • Beuten, J., Gelfond, J. A. L., Martinez-Fierro, M. L., Weldon, K. S., Crandall, A. C., Rojas-Martinez, A., Thompson, I. M., Leach, R. J. (2009). Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. Carcinogenesis 30: 1372-1379 [Abstract] [Full Text]  
  • Dhar, M., Mascareno, E. M., Siddiqui, M. A. Q. (1997). Two Distinct Factor-binding DNA Elements in Cardiac Myosin Light Chain 2 Gene Are Essential for Repression of Its Expression in Skeletal Muscle. ISOLATION OF A cDNA CLONE FOR REPRESSOR PROTEIN NISHED. J. Biol. Chem. 272: 18490-18497 [Abstract] [Full Text]  
  • Imagawa, S., Yamamoto, M., Miura, Y. (1997). Negative Regulation of the Erythropoietin Gene Expression by the GATA Transcription Factors. Blood 89: 1430-1439 [Abstract] [Full Text]  
  • Carroll, J. M., Taichman, L. B. (1992). Characterization of the human involucrin promoter using a transient beta-galactosidase assay. J. Cell Sci. 103: 925-930 [Abstract]  
  • Vorachek, W. R., Steppan, C. M., Lima, M., Black, H., Bhattacharya, R., Wen, P., Kajiyama, Y., Locker, J. (2000). Distant Enhancers Stimulate the Albumin Promoter through Complex Proximal Binding Sites. J. Biol. Chem. 275: 29031-29041 [Abstract] [Full Text]